As of 2020, around half of physicians surveyed in the largest European countries reported there had been a time when they did not prescribe hormone therapy to a patient with vasomotor symptoms associated with menopause because the patient was concerned with the long-term risk of treatment. Furthermore, over 40 percent of physicians did not prescribe hormone therapy because the patient had a comorbid condition.
Share of physicians who reported the following reasons for not prescribing hormone therapy to patients going through menopause in France, Germany, Italy, Spain, and the UK as of 2020
Characteristic
Share of respodents
Patient concern with long-term risk of treatment
48%
Comorbid condition
41.4%
Symptoms not severe enough to warrant treatment
39.5%
Physician concern with long-term risk of treatment
36.2%
Contraindicated with other treatment
32.9%
Patient refusal of prescription drugs
32.2%
Concern of short-term effects
25.7%
Treatment not efficacious enough
17.1%
Patient prefers nonprescription treatment
13.2%
Patient already taking too many tablets for other conditions
11.8%
Treatment only affects VMS and not other menopausal symptoms
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Elsevier. (June 23, 2022). Share of physicians who reported the following reasons for not prescribing hormone therapy to patients going through menopause in France, Germany, Italy, Spain, and the UK as of 2020 [Graph]. In Statista. Retrieved November 05, 2024, from https://www.statista.com/statistics/1366371/physicians-reasons-for-not-prescribing-ht-in-europe/
Elsevier. "Share of physicians who reported the following reasons for not prescribing hormone therapy to patients going through menopause in France, Germany, Italy, Spain, and the UK as of 2020." Chart. June 23, 2022. Statista. Accessed November 05, 2024. https://www.statista.com/statistics/1366371/physicians-reasons-for-not-prescribing-ht-in-europe/
Elsevier. (2022). Share of physicians who reported the following reasons for not prescribing hormone therapy to patients going through menopause in France, Germany, Italy, Spain, and the UK as of 2020. Statista. Statista Inc.. Accessed: November 05, 2024. https://www.statista.com/statistics/1366371/physicians-reasons-for-not-prescribing-ht-in-europe/
Elsevier. "Share of Physicians Who Reported The following Reasons for Not Prescribing Hormone Therapy to Patients Going through Menopause in France, Germany, Italy, Spain, and The Uk as of 2020." Statista, Statista Inc., 23 Jun 2022, https://www.statista.com/statistics/1366371/physicians-reasons-for-not-prescribing-ht-in-europe/
Elsevier, Share of physicians who reported the following reasons for not prescribing hormone therapy to patients going through menopause in France, Germany, Italy, Spain, and the UK as of 2020 Statista, https://www.statista.com/statistics/1366371/physicians-reasons-for-not-prescribing-ht-in-europe/ (last visited November 05, 2024)
Share of physicians who reported the following reasons for not prescribing hormone therapy to patients going through menopause in France, Germany, Italy, Spain, and the UK as of 2020 [Graph], Elsevier, June 23, 2022. [Online]. Available: https://www.statista.com/statistics/1366371/physicians-reasons-for-not-prescribing-ht-in-europe/
